慢性阻塞性肺疾病急性加重期患者感染多重耐药菌的研究进展

Research progress of Multi-drug resistant organism infection in patients with acute exacerbation of chronic obstructive pulmonary disease

慢性阻塞性肺疾病(COPD)患者较为常见,且多数加重期患者需予以抗生素治疗。随着抗生素在临床的广泛应用,耐药菌的问题越发值得我们关注,现已对人类健康造成了巨大的威胁,成为备受关注的问题。多重耐药菌的发生和发展与抗生素的不恰当应用密不可分。细菌感染是COPD急性加重的主要原因,其中有一部分为多重耐药菌感染。本文对多重耐药菌感染与COPD急性加重的关系进行阐述,希望能为临床提供帮助。

Chronic obstructive pulmonary disease(COPD)is common in patients,and most of the exacerbated patients require antibiotic treatment.With the widespread use of antibiotics in clinical practice,the problem of drug-resistant organism has become more and more of concern.It has caused a huge threat and has become a matter of great concern.The occurrence and development of multi-drug resistant organism is inseparable from the widespread use of antibiotics,especially inappropriate use.Bacterial infections are the main cause of acute exacerbations of COPD,and some of them are multi-drug resistant organism infections.In this paper,the relationship between multi-drug resistant organism infections and acute exacerbations of COPD is discussed in the hope that it can provide clinical help.